Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
An Open?label, Single Arm, Multicenter, Phase III Study on the Efficacy, Safety, and Pharmacokinetics of FP?001 42 mg Controlled Release in Patients with Central (Gonadotropin?Dependent) Precocious Pu
Sponsored by QPS Holdings, LLC
Active
$144.6K Funding
4 People
External
Related Topics
pharmacokinetics,
efficacy,
safety,
precocious puberty,
central nervous system
People
Gustavo Cornejo
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator III
Mark Wheeler
Principal Investigator (PI)
Pediatrics
﹒Clinical Professor
Kirsten Anderson
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator IV
Nikki Henderson
(CD)
Orthopedic Surgery
﹒R&D Engineer/Scientist I